SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin gains despite reporting 31% fall in Q2 consolidated net profit

30 Oct 2017 Evaluate

Lupin is currently trading at Rs. 1038.45, up by 37.60 points or 3.76% from its previous closing of Rs. 1000.85 on the BSE.

The scrip opened at Rs. 1005.00 and has touched a high and low of Rs. 1090.00 and Rs. 993.50 respectively. So far 602446 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1572.25 on 06-Feb-2017 and a 52 week low of Rs. 920.00 on 21-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1090.00 and Rs. 991.15 respectively. The current market cap of the company is Rs. 45251.78 crore.

The promoters holding in the company stood at 46.80%, while Institutions and Non-Institutions held 40.05% and 13.14% respectively.

The company has reported 40.45% fall in its net profit at Rs 388.90 crore for the quarter ended September 30, 2017 as compared to Rs 653.08 crore for the same quarter in the previous year. The total income of the company decreased by 10.64% at Rs 2654.33 crore for Q2FY18 as compared Rs 2970.23 crore for the corresponding quarter previous year.

On consolidate basis, the company has reported 31.29% fall in its net profit at Rs 455.01 crore for the quarter under review as compared to Rs 662.19 crore for the corresponding quarter in the FY17. Total income of the company decreased 6.75% at Rs 4026.00 crore for quarter under review as compared to Rs 4317.62 crore for the same quarter ended previous year.

Lupin Share Price

2459.75 17.40 (0.71%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×